Symatese Overview
Company Headquarters: Chaponost, France
Founded: 1982
Workforce: ~250
Company Working: Symatese is engaged in the business of biopolymers extraction and development of medical devices. The company manufactures products used in plastic surgeries and medical aesthetics with hyaluronic acid and collagen. The company’s manufacturing process complies with the European directive MDD93/42 and Quality System Regulation CFR820. Symatese Group comprises four companies, namely Symatese, Symatese Aesthetics, Symatese Device, and Symatese Shanghai and CORMOVE. The company has three production sites in France. Symatese recorded sales revenue worth USD 15.76 Million and its subsidiary Symatese Device accounted for USD 20.17 Million by the end of 2017.
Strategy
Symatese is focusing on R&D to develop its business domains. Furthermore, it is also focusing on making industrial relationships with leading medical companies to expand the customer base and gain higher profit margins.
